.FDA refuses psychedelic MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Downtrends to Authorize MDMA Therapy, Finding More Research Study The The Big Apple TimesFDA Declines Ecstasy-Based Medicine The Commercial JournalFDA refuses to authorize unfamiliar MDMA treatment to deal with post-traumatic stress disorder, along with ask for even more hearing information CNNFDA declines first psychedelic to treat post-traumatic stress disorder, asking for additional study The Washington Article.